At health.tech, I lead the scientific programme for the 2027 summit’s Preventive Health, Diagnostics, Women’s Health and Wearables stage. I’ve brought in 150+ healthcare professionals and health authority representatives from 12+ regions, and manage relationships and communications with 220+ speakers.
At radiomics.bio, I took ownership of European Commission deliverable D8.5 for the EUCAIM consortium after the project lead left. I coordinated 25 institutions across 12 countries, conducted 24 stakeholder interviews and delivered the service portfolio and sustainability strategy on time as first-named author.
My work also spans market access and clinical research: at Bristol Myers Squibb, I developed a pricing and policy proposal for a β-thalassemia therapy in Brazil’s public health system, and at UCLH I supported a clinical study in cancer patients. I bring that experience to programme work, evidence generation and healthcare stakeholder engagement.

